Anti-Human VWF A1 domain Recombinant Antibody
-
产品编号
YR1265
-
别名
科研级 Caplacizumab ( 卡拉西单抗 ), Anti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1265 |
| Alias | 科研级 Caplacizumab ( 卡拉西单抗 ), Anti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab |
| Size | 1mg, 5mg |
| Molecular Name | Caplacizumab |
| CAS Number | 915810-67-2 |
| Molecular Weight | 27.88 kDa |
| Target | VWF A1 domain[Homo sapiens] |
| Antibody Isotype | VH-VH |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Caplacizumab (INN, trade name Cablivi) is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis. |
| Remarks | This product is for research use only. |
0